{
    "Trade/Device Name(s)": [
        "PENTRA C200",
        "I.S.E. Module",
        "ABX PENTRA Glucose HK CP"
    ],
    "Submitter Information": "Horiba ABX SAS",
    "510(k) Number": "K103788",
    "Predicate Device Reference 510(k) Number(s)": [
        "K052007"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CFR",
        "JGS",
        "CEM",
        "CGZ",
        "JJE"
    ],
    "Summary Letter Date": "November 4, 2011",
    "Summary Letter Received Date": "November 7, 2011",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose",
        "Sodium",
        "Potassium",
        "Chloride"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma",
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "PENTRA C200"
    ],
    "Method(s)/Technology(ies)": [
        "Absorbance photometry",
        "Ion selective electrode (ISE)",
        "Colorimetry",
        "Potentiometry",
        "Enzymatic hexokinase method"
    ],
    "Methodologies": [
        "Discrete photometric analysis",
        "Enzymatic colorimetric determination",
        "Ion selective electrode analysis"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Module",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for PENTRA C200 clinical chemistry analyzer, I.S.E. Module, and ABX PENTRA Glucose HK CP reagent for quantitative measurement of glucose and electrolytes in serum, plasma, and urine.",
    "Indications for Use Summary": "Intended for quantitative measurements of glucose, sodium, potassium, and chloride in serum, plasma, and urine for diagnosis and treatment of disorders such as carbohydrate metabolism disorders and electrolyte imbalances in clinical laboratories.",
    "fda_folder": "Clinical Chemistry"
}